Selank Price: $23.75 With the Code and No Prescriber Fee

The Selank price on the listing we link is $47.50 for a 10 mg vial, marked down from $60.00, and the code PEPTIDEDECK halves the current figure to $23.75. Divide by the ten milligrams printed on the label and you have $2.38 per milligram, which is the unit to carry into any comparison you make after this page.

Three numbers are in play and only two of them are yours. The $60.00 is a struck-through reference price the seller sets and can move. The $47.50 is what the listing charges today. The $23.75 is what reaches your card if the code applies, and the only one of the three that describes a real transaction is the last one. Treat a crossed-out figure on any research listing as marketing rather than as evidence of a discount, and judge the offer on the number at the bottom of the cart.

Per milligram is the unit that survives a change of packaging. Vendors in this market quote per vial, and vial sizes are not standard across sellers, so two listings at similar prices can differ by half on the material inside. Work out cost per milligram before you compare anything, and do it on the label quantity rather than on an assay figure, for reasons the third section gets into.

We earn a commission if you buy through our link, which our affiliate disclosure sets out in full. It is why the list price is printed here next to the discounted one, and why the section on what this price does not buy has not been softened.

How much does Selank cost is a different question at three vials than at one, and the listing publishes the arithmetic rather than hinting at it. Buying three takes $1.43 off each vial, so $46.08 apiece and $138.23 for the set, which is 3% off. Five takes $2.38 off each, so $45.13 apiece and $225.63 in total, which is 5%. Ten takes $4.75 off each, so $42.75 apiece and $427.50 in total, which is 10%.

Every one of those figures is a reduction from the $47.50 list price, not from the discounted price. The code is also a reduction from list. Whether the two combine is decided by the checkout, and it is not documented anywhere we can point to, so we are not going to publish a stacked number we cannot verify. Build the cart both ways, once with a single vial and the code and once on a tier, and compare the two totals on screen before you enter a card.

Free shipping starts once the order total passes $250, and the tiers land either side of that line in a way worth noticing. Five vials at the tier price come to $225.63, which is under. Ten come to $427.50, which is comfortably over. A single vial at $23.75 is nowhere near it, so fold the shipping charge into your per milligram figure before you decide the price is good, because on an order that size it is not a rounding error.

There is one argument for the larger tiers and one against. In favour: a certificate is batch specific, so ten vials from one batch are covered by one document you have read, where ten bought over a year are ten batches and ten documents. Against: the saving is 10%, and the exposure is the whole order, on a substance with no approved use and no return path beyond the vendor's policy.

The Selank cost per vial is set against a label quantity of 10 mg, and two published certificates say the vials contained more than that. The February 2026 certificate for lot 29-01260229, run by MZ Biolabs in Tucson, reports a measured quantity of 12.29 mg per vial at 99.32% purity. The current batch, 29-05260628, certified by Kovera Labs in June 2026, reports net content of 11.86 mg at 99.371% purity against a specification of more than 98%.

Run the arithmetic on those and the per milligram figure moves. At $23.75 for 12.29 mg you are paying $1.93 per milligram. At 11.86 mg you are paying $2.00. Against the $2.38 the label supports, that is a real difference, and it is also the number we would not build a purchase on. Overfill is lot specific. It describes two batches that were weighed, not a policy the vendor has promised to repeat, and the next batch is entitled to sit at 10.0 mg and still pass its own specification.

So price it at $2.38 per milligram, treat anything above the label as a bonus that may not recur, and give the vendor credit for publishing a figure it did not have to publish. Very little in this market is checkable at all. A measured quantity that sits above the label, printed on a document with a lot number on it, is one of the few claims here you can actually hold somebody to.

On the drugs this site usually covers there are at least three prices for the same molecule: a manufacturer list price, a negotiated cash price, and whatever a plan leaves the patient to pay. That structure is why our guide to what GLP-1 care actually costs runs to several thousand words, and why our comparison of a retatrutide vial against a month of Wegovy has two real prices in it. Selank has none of that. It has one price, from one kind of seller.

The reason is regulatory rather than commercial. Selank has no FDA approval for any indication, so there is no approved product, no NDC and no formulary position. It is also absent from the 503A bulks list, the register of substances a compounding pharmacy may lawfully work from, on a page FDA marks as current as of 05/14/2026. On FDA's own compounding page, current as of 04/22/2026, Selank acetate (TP-7) appears in the table of bulk drug substances nominated but withdrawn, not in the category 2 table above it. Somebody put it forward for consideration and then took the nomination back.

That is worth stating plainly, because a great deal of writing about Selank has it as an FDA category 2 substance or as banned from compounding, and neither is true of the current lists. FDA describes the withdrawn table as substances previously in category 2 whose nominations the nominators took back. Selank sits outside the regulated market rather than prohibited within it.

The practical result is that a compounding pharmacy has nothing to work from, so there is no compounded Selank prescription to price, no clinic route, and nobody standing between you and a warehouse. Compare that with the compound in our NAD+ price breakdown, where a clinic channel genuinely exists and the interesting question is why a drip session costs a hundred times what the raw material does. For Selank there is no second column. That is not an oversight in this article, it is the market.

Search for Selank and a large part of what comes back is nasal spray sold by nootropic retailers, priced per bottle. Those listings and this one are not comparable on price, and the reason is not that one is dearer. It is that most spray listings do not tell you how much peptide is in the bottle.

A per bottle price with no stated milligram content cannot be converted into a per milligram figure at all. You are comparing $2.38 per milligram against a number that has no denominator. Some spray listings do state a total peptide content and a fill volume, and if yours does, divide and compare. If it does not, the honest position is that you cannot rank them, and a bottle that looks cheaper may hold a fraction of the material.

The format also changes what the price ought to include, which our page on buying Selank as a nasal spray works through. A sealed powder and a liquid already in a pump bottle raise different questions about sterility, preservatives and shelf life once opened, and pricing them as the same thing picks wrong reliably.

The cheapest thing to verify about this purchase is the price, and it is the least important thing on the page. Two things cost nothing to check and outrank it.

The first is testing scope. FDA's stated concern about compounded Selank is immunogenicity for certain routes of administration, arising from the potential for aggregation and peptide-related impurities, and the agency records that it lacks important information about safety issues raised by selank acetate given to humans. That is a testing question, not a sentiment. Purity by HPLC and identity by mass spectrometry tell you what the molecule is. An endotoxin result tells you whether the batch is clean enough for anything that would be injected, and a sterility screen tells you whether anything grew.

Which certificate you are shown therefore matters more than the discount. The February 2026 document for lot 29-01260229 carries purity and identity and stops there: no endotoxin test, no sterility test, no heavy metals. The June 2026 document for batch 29-05260628 adds a bacterial endotoxin analysis by kinetic LAL to USP Chapter 85, reporting less than 0.20 EU/mL against an acceptance limit of 0.5 EU/mL, a rapid sterility screen returning no growth, and heavy metals by ICP-MS with lead, arsenic, cadmium and mercury all below their limits. Same product, same vendor, two very different levels of documentation five months apart. Ask which batch you are being sent and read that batch's certificate rather than whichever one is easiest to find.

The second is what happens if something goes wrong, and here $23.75 buys nothing at all. No pharmacist checks the order, no prescriber has seen you, no state board has jurisdiction and no insurer can be appealed to. What you have is the vendor's written policy and a chargeback through your card issuer, which is a reason to pay by card and keep the order summary.

$2.38 per milligram is the number to keep, because it survives a change of vial size and exposes the difference between a genuine reduction and a rearranged list price. Everything else here moves: the tiers, the shipping threshold, the assayed quantity, the batch.

The second thing to keep is the absence. There is no prescription price for Selank in the United States, so any page quoting you a clinic figure has invented it, and that is a more useful test of a source than anything it says about the compound.